Apply for FundingEvery year, Crohn’s and Colitis Canada launches grant competitions for two funding programs, Grants-in-Aid of Research and Innovations in IBD Research. Here you will learn more about each grant program, and how to submit an application.
Crohn’s and Colitis Canada is delighted to announce the launch of its 2021 Grants-in-Aid of Research (GIA) Competition. The GIA program supports research projects directly related to IBD that are aligned with Crohn’s and Colitis Canada’s Promise and strategic directions. Funding is limited to a maximum of $125,000 per year, for up to three years, contingent upon available funds.
Changes to the Competition
Please note the following updates to our GIA competition:
- Up to 20-30% of the GIA funds will be reserved for Early Career Investigators; and
- The 2021 competition is open to researchers with total extramural research funds of no more than $250,000 as a Principal Investigator
Why the Changes?
Given the COVID-19 situation, and expected lower revenues, we have implemented changes to the grant eligibility for the 2021 GIA grant competition to ensure we continue to support the IBD research community during these challenging times.
These changes address the need to support critical mass for IBD research and retain talent as much as possible.
The revised grant eligibility will be assessed at the end of the 2021 grant competition. Changes may be introduced in 2022 depending on the results of our assessment at that time.
Applications must be submitted through a two-stage application process. Applicants who submit a Letter of Intent are invited to submit a Full Application by the deadline specified.
- Notices of Intent to Apply are due by 5 pm (EST) on Wednesday, March 10, 2021
- Full applications are due by 5 pm (EST) on Wednesday, April 7, 2021.
Applying for a Grants-in-Aid of Research grant
Applicants must complete the online applications available via the proposalCENTRAL website. Applications are not accepted via email or mail.
Review Application Instructions for details on how to submit an application.
Please review the grant guidelines carefully as changes have been introduced to the eligibility criteria for the 2021 grant competition.
1. Beginning with the 2021 Grants-in-Aid of Research competition, Principal Investigators may not hold more than a cumulative total of $250,000 a year in extramural funding (includes foundation and industry support) unless they are in their final year of funding. Intramural funds are not counted towards this total.
2. Crohn’s and Colitis Canada is committed to supporting early career
researchers. As part of this commitment, 20%-30% of the GIA funds will be reserved for early career researchers beginning with the 2021 GIA competition.
Update - Due to COVID19, Crohn’s and Colitis Canada expects lower revenues for 2021. We, therefore, will not be holding a 2021 Innovations in IBD grant competition.
Crohn's and Colitis Canada invites applications for an Innovations Grant, to fund novel or innovative approaches to IBD research. This grant is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). Our organization seeks mission relevance and excellence as well as innovation.
Grants to a maximum of $50,000 for one year may be awarded.
- Applications are due by 5 pm (EST) on Friday, January 31, 2020.
Submitting your Innovations in IBD application
Applicants must complete the online application available via the proposalCENTRAL website. Applications are not accepted via email or mail.
Please see the Grant Guidelines for details on grant eligibility, and nomination and selection procedures.
For technical support with your online application, contact proposalCENTRAL:
Weekdays, 8:00 am to 5:00 pm EST
For program information or application content requirements, contact Crohn’s and Colitis Canada:
Research Grants Administrator
Telephone: (416) 920-5035 ext. 252